Download in electronic PDF format for $25



Search the Complete Journal Archives

Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives

Author(s):  Trimble John,Light Bob

Issue:  May/Jun 2016 - Volume 20, Number 3
View All Articles in Issue

Abstract:  Transdermal compositions for pain management are comprised of nonsteroidal anti-inflammatory drugs, opioid drugs, and adjuvant drugs acting on: voltage-gated channels, gamma-aminobutyric acid receptors, acute musculoskeletal pain, and as an antidepressant. In this work, baclofen, bupivacaine, cyclobenzaprine, diclofenac, gabapentin, ibuprofen, ketamine, and pentoxifylline were loaded in transdermal compositions, prepared using a mixture of lipids (isopropyl palmitate and mineral oil) and one of two selected penetration enhancer mixtures: alkyl dimethicone, phenyl trimethicone, and polyoxyethylene sorbitan monostearate; and cetostearyl polyoxyethylene ether and ethylene oxide/propylene oxide copolymer. The influence of penetration enhancers on transdermal delivery was evaluated using Franz-type diffusion cells and Normal Human 3D Model of Epidermal Tissue. Results showed that drug delivery is affected by the penetration enhancer used in the transdermal composition.

Related Keywords: John Trimble, BS Chemistry, Bob Light, BS Pharm, penetration enhancers, topical preparation, transdermal permeability, percutaneous drug delivery, skin penetration, pain, analgesia, analgesic, adjuvant pain control, voltage-gated channels, gamma-aminobutyric acid receptors, GABA receptors, acute musculoskeletal pain, muscle relaxants, antidepressants, baclofen, bupivacaine, cyclobenzaprine, diclofenac, gabapentin, ibuprofen, ketamine, pentoxifylline, nonsteroidal anti-inflammatory drug, NSAID, alkyl dimethicone, phenyl trimethicone, polyoxyethylene sorbitan monostearate, cetosteryl polyoxyethylene ether, ethylene oxide, propylene oxide copolymer, emulsifiers, lipids, engineered human skin

Related Categories: EXCIPIENTS, PAIN MANAGEMENT, PEER-REVIEWED, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Trimble John, Light Bob May/Jun 2016 250-256 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106 Buy
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott Mar/Apr 2015 167-173 Buy
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth May/Jun 2014 256-261 Buy
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Heustess Allie, Asbill Scott, Eagerton David, Arnold John Nov/Dec 2014 512-515 Buy
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott Mar/Apr 2015 161-166 Buy
Transdermals: The Skin as Part of a Drug Delivery System Allen Loyd V Jr Jul/Aug 2011 308-315 Buy
Featured Excipient: Flavor Enhancing Agents Allen Loyd V Jr Jan/Feb 2003 48 Buy
Skin Penetration and Antinociception of Topical Gabapentin Formulations Bryson Evan, Asbill Scott, Sweitzer Sarah Nov/Dec 2014 504-511 Buy
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott May/Jun 2013 247-253 Buy